Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.69p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 0
  • Market Cap: £28.02m
Select chart: 1 week | 1 month | 3 month | 6 month
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 43.75 (7.16) (64.25)p n/a n/a n/a n/a 0.0%
31-Dec-26 60.67 0.67 (8.01)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2025 44 n/a 46 68 67 n/a
31-Dec-2026 61 n/a 64 58 55 n/a
31-Dec-2027 92 n/a n/a n/a n/a n/a
 
Earnings
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 3.00p n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 1 1 1 1 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 2 2 1 1 0
 
Average Rec 7.50 7.50 7.50 5.00 5.00 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 2.69p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.34
52 Week Low 1.60
Volume 0
Shares Issued 1,041.69m
Market Cap £28.02m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.58% below the market average13.58% below the market average13.58% below the market average13.58% below the market average13.58% below the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Price Trend
15.45% above the market average15.45% above the market average15.45% above the market average15.45% above the market average15.45% above the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Income Not Available
Growth
62.57% above the market average62.57% above the market average62.57% above the market average62.57% above the market average62.57% above the market average
81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average81.25% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

STX Key Personnel

CEO Anders Lundstrom

Top of Page